Stock Analiz

STE vs SNN stock comparison

STERIS vs. Smith & Nephew · data as of November 13, 2026

STERIS (STE) has a market value of about $25.7B, Smith & Nephew (SNN) about $13.1B. Over their latest twelve months STERIS had revenue of $6.2B and Smith & Nephew $6.3B.

On our five checks STERIS scores higher: 3.0 out of 5 (average) against 2.6 (average).

By area, the stronger company is Smith & Nephew on value; STERIS on track record; STERIS on financial health; STERIS on shareholder returns.

Smith & Nephew is cheaper on earnings (P/E 21.3 vs. 31.4), while STERIS grew revenue faster over five years (13.8% vs. 6.2% a year).

STERIS leads on 14 of the compared lines and Smith & Nephew on 10.

Side by side

STESNN
Size and price
Market cap$25.7B$13.1B
Share price$264.32$31.28
Score
Overall score (of 5)3.02.6
Value03
Future growth22
Track record31
Financial health53
Shareholder returns54
Valuation
P/E (TTM)31.421.3
Forward P/E21.713.3
Price / free cash flow27.415.3
Price / sales4.22.1
EV / EBITDA16.211.3
PEG2.763.07
DCF value vs. price−43%−17%
Business
Revenue$6.2B$6.3B
Net income$827M$635M
Free cash flow$937M$855M
Net margin13.4%10.1%
Gross margin (5-yr avg.)43.9%69.5%
ROIC (5-yr avg.)6.8%6.1%
Growth
Revenue growth (1 yr)8.7%6.1%
Revenue growth (5 yrs, per year)13.8%6.2%
EPS growth (5 yrs, per year)11.4%6.9%
Balance sheet and payouts
Net cash (cash minus debt)-$1.4B-$2.6B
Dividend yield1.04%2.54%
Shareholder yield2.0%6.4%
Analysts
Upside to average target+6%+6%
Consensus ratingBuyHold

Highlighted = the better figure on that line. Revenue, net income and free cash flow: STE TTM to September 30, 2026, SNN TTM to June 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, STERIS or Smith & Nephew?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) STERIS scores 3.0 out of 5 and Smith & Nephew 2.6; the table shows where each one is stronger.

Is STERIS cheaper than Smith & Nephew?

On trailing earnings, Smith & Nephew trades at a P/E of 21.3 and STERIS at 31.4, so Smith & Nephew is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, STERIS or Smith & Nephew?

Over five years STERIS grew revenue about 13.8% a year and Smith & Nephew about 6.2% a year.

Which pays a higher dividend?

STERIS yields 1.04% and Smith & Nephew 2.54%.

Full STERIS analysis → Full Smith & Nephew analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.